Sign In
Buy HIMS
$34.38
+0 (+0%)
At Close: Jul 13, 2026
Is Most-Watched Stock Hims & Hers Health, Inc. (HIMS) Worth Betting on Now?
10:01am, Monday, 13'th Jul 2026
Hims & Hers Health (HIMS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Hims & Hers Health: The Market Still Doesn't Get It
08:34am, Wednesday, 08'th Jul 2026
FDA staff challenged seven compounded peptides, but Hims & Hers continues expanding internationally and strengthening its core healthcare platform beyond longevity therapies. The $400 million JPMorgan
Here's Why Hims & Hers Health, Inc. (HIMS) Fell More Than Broader Market
06:46pm, Tuesday, 07'th Jul 2026
Hims & Hers Health, Inc. (HIMS) closed the most recent trading day at $36.17, moving 5.51% from the previous trading session.
Hims & Hers Health vs. Teladoc Health: Which Healthcare Stock Is a Better Buy in 2026?
08:45pm, Monday, 06'th Jul 2026
Hims & Hers Health continues to drive impressive growth through its subscription-based consumer wellness platform. Teladoc Health maintains a dominant market share with over 100 million global members
As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner
02:20pm, Monday, 06'th Jul 2026
The healthcare sector is one of the best-performing sectors in the S&P 500 over the past month, with a gain of around 6%. But while that rebound has been led by a handful of mega-cap Big Pharma compan
HIMS Breakout Signals Structural Business Transformation
11:29am, Friday, 03'rd Jul 2026
The stock rebounded from below $14 after a regulatory shock and is now trading above $37 on a diversified growth narrative. Monthly weight-loss subscriber additions exceed one hundred thousand, transf
Amplify Online Retail ETF Rides a Summer Surge in Performance
12:24pm, Thursday, 02'nd Jul 2026
The Amplify Online Retail ETF (IBUY) has rallied over the past month, signaling a robust appetite for online consumer discretionary spending despite persistent macroeconomic headwinds. Outsized gains
Hims & Hers stock jumps as Canaccord lifts target price ahead of FDA review
02:15pm, Wednesday, 01'st Jul 2026
Hims & Hers Health shares (HIMS) surged 9% on Wednesday after Canaccord Genuity raised its price target on the telehealth company, citing improving sales trends, momentum in its weight-loss business,
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know
10:01am, Wednesday, 01'st Jul 2026
Recently, Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine what the stock has in store.
Hims & Hers Health, Inc. (HIMS) Stock Falls Amid Market Uptick: What Investors Need to Know
06:46pm, Monday, 29'th Jun 2026
In the most recent trading session, Hims & Hers Health, Inc. (HIMS) closed at $33.39, indicating a -1.62% shift from the previous trading day.
OMCL or HIMS: Which Is the Better Value Stock Right Now?
12:40pm, Friday, 26'th Jun 2026
Investors interested in Medical Info Systems stocks are likely familiar with Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two companies is the best option for those looking
Hims' obesity drug business may get boost as employers drop coverage
06:04am, Thursday, 25'th Jun 2026
Telehealth provider Hims and Hers Health may get a boost next year from employers dropping coverage of weight-loss drugs like Novo Nordisk's Wegovy and Eli Lilly's Zepbound and Foundayo to rein in
Hims & Hers Health, Inc. (HIMS) Sees a More Significant Dip Than Broader Market: Some Facts to Know
06:46pm, Tuesday, 23'rd Jun 2026
Hims & Hers Health, Inc. (HIMS) closed the most recent trading day at $32.96, moving 1.73% from the previous trading session.
A Look at Hims & Hers Health Inc (HIMS) After 5.4% Decline -- GF Value $38.53 vs Price $33.54
07:59pm, Monday, 22'nd Jun 2026
On June 22, 2026, Hims and Hers Health Inc (HIMS) shares fell 5.4% today, trading at $33.54. Over the past 52 weeks, the stock has ranged from a low of $13.74 to
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Friday, 19'th Jun 2026
Recently, Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine what the stock has in store.
